Combined [68 Ga]Ga-PSMA-11 and low-dose 2-[18F]FDG PET/CT using a long-axial field of view scanner for patients referred for [177Lu]-PSMA-radioligand therapy.
Digital PET
PET/CT
Positron-emission-tomography
Total-body PET
Ultra-long FOV PET
Whole-body PET
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
28
07
2022
accepted:
01
09
2022
pubmed:
23
9
2022
medline:
24
1
2023
entrez:
22
9
2022
Statut:
ppublish
Résumé
Performing 2-[ Fourteen patients referred for evaluation for PSMA-RLT received [ The combined protocol identified additional lesions with low or absent PSMA-expression but high FDG-avidity in 1/14 (7%) patients. The protocol was easily implemented and well tolerated by all patients. Additional low-dose 2-[
Identifiants
pubmed: 36136102
doi: 10.1007/s00259-022-05961-z
pii: 10.1007/s00259-022-05961-z
pmc: PMC9852199
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Radiopharmaceuticals
0
Lutetium-177
BRH40Y9V1Q
Radioisotopes
0
Gallium-68
98B30EPP5S
gallium 68 PSMA-11
0
Gallium Radioisotopes
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
951-956Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s).
Références
Ann Nucl Med. 2021 Apr;35(4):485-492
pubmed: 33550515
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):642-651
pubmed: 31865408
JAMA Oncol. 2021 Dec 1;7(12):1757-1758
pubmed: 34436535
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1966-1975
pubmed: 33244618
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4490-4502
pubmed: 35852557
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4456-4462
pubmed: 34155538
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544
pubmed: 31440799
J Nucl Med. 2022 Oct;63(10):1484-1488
pubmed: 35273096
J Nucl Med. 2018 Jan;59(1):3-12
pubmed: 28935835
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Eur J Nucl Med Mol Imaging. 2021 Jul;48(8):2395-2404
pubmed: 33797596
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1611-20
pubmed: 27260521
J Nucl Med. 2019 Mar;60(3):299-303
pubmed: 30733314
J Nucl Med. 2022 Apr;63(4):622-628
pubmed: 34385335
J Nucl Med. 2020 Feb;61(2):189-193
pubmed: 31324710
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):160-167
pubmed: 31628514